Taking a different approach, GWAS analysis for copy number variation using the STAR*D sample and a health system repository revealed a modest enrichment of chromosomal duplications among treatment refractory depression cases, and a deletion in PABPC4L uniquely affecting treatment resistant MDD patients, but was restricted to only a small number of subjects [110]. This evidence concerns the gene PABPC4L and depressive symptom measurement.